Amneal Pharmaceuticals, Inc. (AMRX)
21.38
-0.32
(-1.50%)
USD |
NASDAQ |
Nov 13, 16:00
21.38
0.00 (0.00%)
After-Hours: 19:59
Amneal Pharmaceuticals Total Assets (Quarterly) : 5.267B for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 5.267B |
| June 30, 2026 | 3.776B |
| March 31, 2026 | 3.540B |
| December 31, 2025 | 3.678B |
| September 30, 2025 | 3.600B |
| June 30, 2025 | 3.423B |
| March 31, 2025 | 3.365B |
| December 31, 2024 | 3.501B |
| September 30, 2024 | 3.461B |
| June 30, 2024 | 3.510B |
| March 31, 2024 | 3.456B |
| December 31, 2023 | 3.473B |
| September 30, 2023 | 3.687B |
| June 30, 2023 | 3.701B |
| March 31, 2023 | 3.627B |
| December 31, 2022 | 3.799B |
| September 30, 2022 | 3.874B |
| June 30, 2022 | 4.041B |
| March 31, 2022 | 3.889B |
| December 31, 2021 | 3.940B |
| September 30, 2021 | 3.974B |
| June 30, 2021 | 4.023B |
| March 31, 2021 | 3.960B |
| December 31, 2020 | 4.006B |
| September 30, 2020 | 4.038B |
| Date | Value |
|---|---|
| June 30, 2020 | 4.057B |
| March 31, 2020 | 4.391B |
| December 31, 2019 | 3.666B |
| September 30, 2019 | 3.704B |
| June 30, 2019 | 4.262B |
| March 31, 2019 | 4.385B |
| December 31, 2018 | 4.353B |
| September 30, 2018 | 4.582B |
| June 30, 2018 | 4.545B |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 1.342B |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | 1.696B |
| December 31, 2016 | 1.823B |
| September 30, 2016 | 2.120B |
| June 30, 2016 | 1.850B |
| March 31, 2016 | 1.886B |
| December 31, 2015 | 1.922B |
| September 30, 2015 | 1.996B |
| June 30, 2015 | 2.032B |
| March 31, 2015 | 1.782B |
| December 31, 2014 | 1.080B |
| September 30, 2014 | 1.092B |
| June 30, 2014 | 1.059B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| TG Therapeutics, Inc. | 1.592B |
| Pfizer Inc. | 204.54B |
| Johnson & Johnson | 197.42B |
| Eli Lilly & Co. | 148.07B |
| Merck & Co., Inc. | 132.77B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.627B |
| Shareholders Equity (Quarterly) | 531.26M |
| Debt to Equity Ratio | 6.180 |
| Current Ratio | 1.871 |
| Net Debt Paydown Yield | -2.00% |